# Jun Zhu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jun-zhu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,170 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 45 |
| i10-index | 110 |
| Last Known Institution | Shenzhen Children's Hospital |
| OpenAlex ID | https://openalex.org/A5025840041 |
| ORCID iD | https://orcid.org/0000-0002-4309-5789 |
| Works | 227 |

## Researcher papers

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study](https://scholariq.org/papers/prevalence-of-diabetes-recorded-in-mainland-china-using-2018-diagnostic-criteria/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study](https://scholariq.org/papers/global-mortality-variations-in-patients-with-heart-failure-results-from-the/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Researcher university

- [Shenzhen Children's Hospital](https://scholariq.org/institutions/shenzhen-children-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.